{"pmid":32463395,"title":"The involvement of the central nervous system in patients with COVID-19.","text":["The involvement of the central nervous system in patients with COVID-19.","Coronaviruses disease (COVID-19) has caused major outbreaks. A novel variant, SARS-CoV-2, is responsible for COVID-19 pandemic. Clinical presentations and pathological mechanisms of COVID-19 are broad. The respiratory aspect of the disease has been extensively researched. Emerging studies point out the possibility of the central nervous system (CNS) involvement by COVID-19. Here, we discuss the current evidence for CNS involvement in COVID-19 and highlight that the high pathogenicity of SARS-CoV-2 might be due to its neuroinvasive potential.","Rev Neurosci","Saleki, Kiarash","Banazadeh, Mohammad","Saghazadeh, Amene","Rezaei, Nima","32463395"],"abstract":["Coronaviruses disease (COVID-19) has caused major outbreaks. A novel variant, SARS-CoV-2, is responsible for COVID-19 pandemic. Clinical presentations and pathological mechanisms of COVID-19 are broad. The respiratory aspect of the disease has been extensively researched. Emerging studies point out the possibility of the central nervous system (CNS) involvement by COVID-19. Here, we discuss the current evidence for CNS involvement in COVID-19 and highlight that the high pathogenicity of SARS-CoV-2 might be due to its neuroinvasive potential."],"journal":"Rev Neurosci","authors":["Saleki, Kiarash","Banazadeh, Mohammad","Saghazadeh, Amene","Rezaei, Nima"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32463395","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1515/revneuro-2020-0026","keywords":["ace2","covid-19","sars-cov-2","anosmia","central nervous system (cns)","coronavirus"],"topics":["Mechanism"],"weight":1,"_version_":1668079521234944001,"score":9.490897,"similar":[{"pmid":32399719,"title":"Involvement of the Nervous System in SARS-CoV-2 Infection.","text":["Involvement of the Nervous System in SARS-CoV-2 Infection.","As a severe and highly contagious infectious disease, coronavirus disease 2019 (COVID-19) has caused a global pandemic. Several case reports have demonstrated that the respiratory system is the main target in patients with COVID-19, but the disease is not limited to the respiratory system. Case analysis indicated that the nervous system can be invaded by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and that 36.4% of COVID-19 patients had neurological symptoms. Importantly, the involvement of the CNS may be associated with poor prognosis and disease worsening. Here, we discussed the symptoms and evidence of nervous system involvement (directly and indirectly) caused by SARS-CoV-2 infection and possible mechanisms. CNS symptoms could be a potential indicator of poor prognosis; therefore, the prevention and treatment of CNS symptoms are also crucial for the recovery of COVID-19 patients.","Neurotox Res","Li, Hao","Xue, Qun","Xu, Xingshun","32399719"],"abstract":["As a severe and highly contagious infectious disease, coronavirus disease 2019 (COVID-19) has caused a global pandemic. Several case reports have demonstrated that the respiratory system is the main target in patients with COVID-19, but the disease is not limited to the respiratory system. Case analysis indicated that the nervous system can be invaded by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and that 36.4% of COVID-19 patients had neurological symptoms. Importantly, the involvement of the CNS may be associated with poor prognosis and disease worsening. Here, we discussed the symptoms and evidence of nervous system involvement (directly and indirectly) caused by SARS-CoV-2 infection and possible mechanisms. CNS symptoms could be a potential indicator of poor prognosis; therefore, the prevention and treatment of CNS symptoms are also crucial for the recovery of COVID-19 patients."],"journal":"Neurotox Res","authors":["Li, Hao","Xue, Qun","Xu, Xingshun"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32399719","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1007/s12640-020-00219-8","keywords":["covid-19","central nervous system","infection","sars-cov-2"],"topics":["Mechanism","Diagnosis","Treatment"],"weight":1,"_version_":1666865855036653569,"score":204.35216},{"pmid":32478706,"title":"Severe COVID-19 Cases: Is Respiratory Distress Partially Explained by Central Nervous System Involvement?","text":["Severe COVID-19 Cases: Is Respiratory Distress Partially Explained by Central Nervous System Involvement?","The main characteristics and challenging symptoms of COVID-19, caused by the novel coronavirus SARS-CoV-2, are related to re-spiratory distress. Although most patients have mild symptoms such as fever, headache, cough, myalgia and anosmia, some develop acute respiratory distress syndrome, leading to death in many cases. Human coronavirus (CoVs) were responsible for two previ-ous worldwide outbreaks: Severe Acute Respiratory Syndrome (SARS-CoV) and Middle East Respiratory Syndrome (MERS-CoV). Several reports of these outbreaks demonstrated that these diseases affected the central nervous system (CNS).[1] Thus, for the current COVID-19 pandemic, a crucial question arises: does CNS affection at least partially explain the respiratory distress commonly found in these patients?","MEDICC Rev","Machado-Curbelo, Calixto","32478706"],"abstract":["The main characteristics and challenging symptoms of COVID-19, caused by the novel coronavirus SARS-CoV-2, are related to re-spiratory distress. Although most patients have mild symptoms such as fever, headache, cough, myalgia and anosmia, some develop acute respiratory distress syndrome, leading to death in many cases. Human coronavirus (CoVs) were responsible for two previ-ous worldwide outbreaks: Severe Acute Respiratory Syndrome (SARS-CoV) and Middle East Respiratory Syndrome (MERS-CoV). Several reports of these outbreaks demonstrated that these diseases affected the central nervous system (CNS).[1] Thus, for the current COVID-19 pandemic, a crucial question arises: does CNS affection at least partially explain the respiratory distress commonly found in these patients?"],"journal":"MEDICC Rev","authors":["Machado-Curbelo, Calixto"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32478706","source":"PubMed","week":"202023|Jun 01 - Jun 07","topics":["Mechanism"],"weight":1,"_version_":1668532089492865024,"score":180.63828},{"pmid":32470824,"title":"Delirium in COVID-19: A case series and exploration of potential mechanisms for central nervous system involvement.","text":["Delirium in COVID-19: A case series and exploration of potential mechanisms for central nervous system involvement.","INTRODUCTION: Neuropsychiatric manifestations of the coronavirus disease 2019 (COVID-19) have been described, including anosmia, ageusia, headache, paresthesia, encephalitis and encephalopathy. Little is known about the mechanisms by which the virus causes central nervous system (CNS) symptoms, and therefore little guidance is available regarding potential workup or management options. CASES: We present a series of four consecutive cases, seen by our psychiatry consultation service over a one-week period, each of which manifested delirium as a result of infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). DISCUSSION: The four cases highlighted here all occurred in older patients with premorbid evidence of cognitive decline. Unique features seen in multiple cases included rigidity, alogia, abulia, and elevated inflammatory markers. In all four cases, a change in mental status was the presenting symptom, and three of the four cases lacked significant respiratory symptoms. In addition to discussing unique features of the cases, we discuss possible pathophysiologic explanations for COVID-19 delirium. CONCLUSIONS: Delirium should be recognized as a potential feature of infection with SARS-CoV-2 and may be the only presenting symptom. Based on the high rates of delirium demonstrated in prior studies, hospitals should consider adding mental status changes to the list of testing criteria. Further research is needed to determine if delirium in COVID-19 represents a primary encephalopathy heralding invasion of the CNS by the virus, or a secondary encephalopathy related to systemic inflammatory response or other factors.","Gen Hosp Psychiatry","Beach, Scott R","Praschan, Nathan C","Hogan, Charlotte","Dotson, Samuel","Merideth, Flannery","Kontos, Nicholas","Fricchione, Gregory L","Smith, Felicia A","32470824"],"abstract":["INTRODUCTION: Neuropsychiatric manifestations of the coronavirus disease 2019 (COVID-19) have been described, including anosmia, ageusia, headache, paresthesia, encephalitis and encephalopathy. Little is known about the mechanisms by which the virus causes central nervous system (CNS) symptoms, and therefore little guidance is available regarding potential workup or management options. CASES: We present a series of four consecutive cases, seen by our psychiatry consultation service over a one-week period, each of which manifested delirium as a result of infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). DISCUSSION: The four cases highlighted here all occurred in older patients with premorbid evidence of cognitive decline. Unique features seen in multiple cases included rigidity, alogia, abulia, and elevated inflammatory markers. In all four cases, a change in mental status was the presenting symptom, and three of the four cases lacked significant respiratory symptoms. In addition to discussing unique features of the cases, we discuss possible pathophysiologic explanations for COVID-19 delirium. CONCLUSIONS: Delirium should be recognized as a potential feature of infection with SARS-CoV-2 and may be the only presenting symptom. Based on the high rates of delirium demonstrated in prior studies, hospitals should consider adding mental status changes to the list of testing criteria. Further research is needed to determine if delirium in COVID-19 represents a primary encephalopathy heralding invasion of the CNS by the virus, or a secondary encephalopathy related to systemic inflammatory response or other factors."],"journal":"Gen Hosp Psychiatry","authors":["Beach, Scott R","Praschan, Nathan C","Hogan, Charlotte","Dotson, Samuel","Merideth, Flannery","Kontos, Nicholas","Fricchione, Gregory L","Smith, Felicia A"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32470824","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.genhosppsych.2020.05.008","keywords":["akinetic mutism","covid-19","delirium","encephalopathy","sars-cov-2"],"locations":["ageusia","headache","paresthesia","alogia","abulia"],"topics":["Case Report"],"weight":1,"_version_":1668167109957386240,"score":180.43039},{"pmid":32299017,"pmcid":"PMC7151535","title":"Central nervous system manifestations of COVID-19: A systematic review.","text":["Central nervous system manifestations of COVID-19: A systematic review.","OBJECTIVE: In this systematic review, we will discuss the evidence on the occurrence of central nervous system (CNS) involvement and neurological manifestations in patients with COVID-19. METHODS: MEDLINE (accessed from PubMed) and Scopus from December 01, 2019 to March 26, 2020 were systematically searched for related published articles. In both electronic databases, the following search strategy was implemented and these key words (in the title/abstract) were used: \"COVID 19\" OR \"coronavirus\" AND \"brain\" OR \"CNS\" OR \"neurologic\". RESULTS: Through the search strategy, we could identify two articles about neurological involvement by COVID-19. One of these publications was a narrative review and the other one was a viewpoint. However, the authors scanned the reference lists of the included studies and could identify multiple references. One study, specifically investigated the neurological manifestations of COVID-19 and could document CNS manifestations in 25% of the patients. Most of the studies investigated the manifestations of COVID-19 in general. CONCLUSION: While neurological manifestations of COVID-19 have not been studied appropriately, it is highly likely that some of these patients, particularly those who suffer from a severe illness, have CNS involvement and neurological manifestations. Precise and targeted documentation of neurological symptoms, detailed clinical, neurological, and electrophysiological investigations of the patients, attempts to isolate SARS-CoV-2 from cerebrospinal fluid, and autopsies of the COVID-19 victims may clarify the role played by this virus in causing neurological manifestations.","J Neurol Sci","Asadi-Pooya, Ali A","Simani, Leila","32299017"],"abstract":["OBJECTIVE: In this systematic review, we will discuss the evidence on the occurrence of central nervous system (CNS) involvement and neurological manifestations in patients with COVID-19. METHODS: MEDLINE (accessed from PubMed) and Scopus from December 01, 2019 to March 26, 2020 were systematically searched for related published articles. In both electronic databases, the following search strategy was implemented and these key words (in the title/abstract) were used: \"COVID 19\" OR \"coronavirus\" AND \"brain\" OR \"CNS\" OR \"neurologic\". RESULTS: Through the search strategy, we could identify two articles about neurological involvement by COVID-19. One of these publications was a narrative review and the other one was a viewpoint. However, the authors scanned the reference lists of the included studies and could identify multiple references. One study, specifically investigated the neurological manifestations of COVID-19 and could document CNS manifestations in 25% of the patients. Most of the studies investigated the manifestations of COVID-19 in general. CONCLUSION: While neurological manifestations of COVID-19 have not been studied appropriately, it is highly likely that some of these patients, particularly those who suffer from a severe illness, have CNS involvement and neurological manifestations. Precise and targeted documentation of neurological symptoms, detailed clinical, neurological, and electrophysiological investigations of the patients, attempts to isolate SARS-CoV-2 from cerebrospinal fluid, and autopsies of the COVID-19 victims may clarify the role played by this virus in causing neurological manifestations."],"journal":"J Neurol Sci","authors":["Asadi-Pooya, Ali A","Simani, Leila"],"date":"2020-04-17T11:00:00Z","year":2020,"_id":"32299017","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.jns.2020.116832","keywords":["cns","covid-19","coronavirus","neurological","seizure"],"topics":["Diagnosis"],"weight":1,"_version_":1666138493267476480,"score":171.89795},{"pmid":32418055,"title":"COVID-19 virus may have neuroinvasive potential and cause neurological complications: a perspective review.","text":["COVID-19 virus may have neuroinvasive potential and cause neurological complications: a perspective review.","Coronavirus disease 2019 (COVID-19) was reported at the end of 2019 in China for the first time and has rapidly spread throughout the world as a pandemic. Since COVID-19 causes mild to severe acute respiratory syndrome, most studies in this field have only focused on different aspects of pathogenesis in the respiratory system. However, evidence suggests that COVID-19 may affect the central nervous system (CNS). Given the outbreak of COVID-19, it seems necessary to perform investigations on the possible neurological complications in patients who suffered from COVID-19. Here, we reviewed the evidence of the neuroinvasive potential of coronaviruses and discussed the possible pathogenic processes in CNS infection by COVID-19 to provide a precise insight for future studies.","J Neurovirol","Sepehrinezhad, Ali","Shahbazi, Ali","Negah, Sajad Sahab","32418055"],"abstract":["Coronavirus disease 2019 (COVID-19) was reported at the end of 2019 in China for the first time and has rapidly spread throughout the world as a pandemic. Since COVID-19 causes mild to severe acute respiratory syndrome, most studies in this field have only focused on different aspects of pathogenesis in the respiratory system. However, evidence suggests that COVID-19 may affect the central nervous system (CNS). Given the outbreak of COVID-19, it seems necessary to perform investigations on the possible neurological complications in patients who suffered from COVID-19. Here, we reviewed the evidence of the neuroinvasive potential of coronaviruses and discussed the possible pathogenic processes in CNS infection by COVID-19 to provide a precise insight for future studies."],"journal":"J Neurovirol","authors":["Sepehrinezhad, Ali","Shahbazi, Ali","Negah, Sajad Sahab"],"date":"2020-05-18T11:00:00Z","year":2020,"_id":"32418055","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1007/s13365-020-00851-2","keywords":["covid-19","coronavirus","nervous system","neuroinvasion","transmission routes"],"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism"],"weight":1,"_version_":1667058206766006272,"score":168.46738}]}